Washington: Medicines for Malaria Venture has developed a framework to evaluate the risk of resistance for the anti-malarial compounds in its portfolio.Resistance defines the longevity of every anti-infective drug, so it is important when developing new medicines for malaria, to check how easily promising anti-malarial compounds will select for resistance. Once this is known, it facilitates the prioritization of not only the most efficacious compounds but also the most robust ones.
RSS can`t chant `NaMo, NaMo`: Bhagwat to cadre
15 jawans killed in Chhattisgarh Naxal attack
Raju Srivastava returns SP ticket in Kanpur
RSS can`t chant `NaMo, NaMo`: Mohan Bhagwat to cadre